MYD88 and colitis: However, IDO-deficient mice have been shown to have ameliorated colitis, associated with significantly reduced expression of members of the TLR-MyD88-NF-kB signaling pathways and significantly reduced levels of pro-inflammatory cytokines, indicating that IDO may also have pro-inflammatory effects on non-T-cells (47).